Dimensional Fund Advisors’s Acrivon Therapeutics ACRV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.4K | Sell |
22,204
-21,950
| -50% | -$26.1K | ﹤0.01% | 3261 |
|
|
2025
Q1 | $90K | Buy |
44,154
+7,091
| +19% | +$14.5K | ﹤0.01% | 3212 |
|
|
2024
Q4 | $223K | Buy |
37,063
+6,239
| +20% | +$37.6K | ﹤0.01% | 3146 |
|
|
2024
Q3 | $216K | Buy |
30,824
+20,758
| +206% | +$145K | ﹤0.01% | 3157 |
|
|
2024
Q2 | $58.4K | Buy |
+10,066
| New | +$58.4K | ﹤0.01% | 3298 |
|